Gnemonol BCAS# 462636-74-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 462636-74-4 | SDF | Download SDF |
PubChem ID | 16148652 | Appearance | Powder |
Formula | C56H42O12 | M.Wt | 907.0 |
Type of Compound | Phenols | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 5-[(2S,3S)-4-hydroxy-6-[(2S,3S)-4-hydroxy-6-[(2S,3S)-4-hydroxy-2-(4-hydroxyphenyl)-6-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-3-yl]-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-3-yl]-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-3-yl]benzene-1,3-diol | ||
SMILES | C1=CC(=CC=C1C=CC2=CC3=C(C(C(O3)C4=CC=C(C=C4)O)C5=CC6=C(C(C(O6)C7=CC=C(C=C7)O)C8=CC9=C(C(C(O9)C1=CC=C(C=C1)O)C1=CC(=CC(=C1)O)O)C(=C8)O)C(=C5)O)C(=C2)O)O | ||
Standard InChIKey | ZVULRZLKHBBDMD-UXGYSEAKSA-N | ||
Standard InChI | InChI=1S/C56H42O12/c57-36-11-3-28(4-12-36)1-2-29-19-42(63)51-45(20-29)66-55(31-7-15-38(59)16-8-31)49(51)34-23-44(65)53-47(25-34)68-56(32-9-17-39(60)18-10-32)50(53)35-24-43(64)52-46(26-35)67-54(30-5-13-37(58)14-6-30)48(52)33-21-40(61)27-41(62)22-33/h1-27,48-50,54-65H/b2-1+/t48-,49-,50-,54+,55+,56+/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Gnemonol B exhibits strong antibacterial activity against vancomycin-resistant Enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA). |
Targets | Antifection |
Gnemonol B Dilution Calculator
Gnemonol B Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.1025 mL | 5.5127 mL | 11.0254 mL | 22.0507 mL | 27.5634 mL |
5 mM | 0.2205 mL | 1.1025 mL | 2.2051 mL | 4.4101 mL | 5.5127 mL |
10 mM | 0.1103 mL | 0.5513 mL | 1.1025 mL | 2.2051 mL | 2.7563 mL |
50 mM | 0.0221 mL | 0.1103 mL | 0.2205 mL | 0.441 mL | 0.5513 mL |
100 mM | 0.011 mL | 0.0551 mL | 0.1103 mL | 0.2205 mL | 0.2756 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Lactulose
Catalog No.:BCC4669
CAS No.:4618-18-2
- 4beta,12-dihydroxyguaian-6,10-diene
Catalog No.:BCN7829
CAS No.:461644-90-6
- Dapagliflozin
Catalog No.:BCC2552
CAS No.:461432-26-8
- Ko 143
Catalog No.:BCC1684
CAS No.:461054-93-3
- Eact
Catalog No.:BCC6313
CAS No.:461000-66-8
- Larixyl acetate
Catalog No.:BCC8195
CAS No.:4608-49-5
- Interiotherin C
Catalog No.:BCN3636
CAS No.:460090-65-7
- Rucaparib (AG-014699,PF-01367338)
Catalog No.:BCC2207
CAS No.:459868-92-9
- 5-[(2R)-2-Aminopropyl]-2,3-dihydro-1-[3-(phenylmethoxy)propyl]-1H-indole-7-carbonitrile
Catalog No.:BCN1438
CAS No.:459868-73-6
- PEAQX
Catalog No.:BCC5495
CAS No.:459836-30-7
- Obeticholic Acid
Catalog No.:BCC5572
CAS No.:459789-99-2
- SB 452533
Catalog No.:BCC7620
CAS No.:459429-39-1
- alpha-Linolenic acid
Catalog No.:BCN8319
CAS No.:463-40-1
- Bay 55-9837
Catalog No.:BCC5932
CAS No.:463930-25-8
- (+)-Borneol
Catalog No.:BCC8376
CAS No.:464-43-7
- (-)-Borneol
Catalog No.:BCC8897
CAS No.:464-45-9
- (-)-Camphor
Catalog No.:BCN7160
CAS No.:464-48-2
- (+)-Camphor
Catalog No.:BCN7161
CAS No.:464-49-3
- Benzopinacol
Catalog No.:BCC8860
CAS No.:464-72-2
- Arenobufagin
Catalog No.:BCN5401
CAS No.:464-74-4
- Quinamine
Catalog No.:BCN6590
CAS No.:464-85-7
- Conquinamine
Catalog No.:BCN6622
CAS No.:464-86-8
- Asiatic acid
Catalog No.:BCN5506
CAS No.:464-92-6
- Pseudotaraxasterol
Catalog No.:BCN5507
CAS No.:464-98-2
Antibacterial activity of stilbene oligomers against vancomycin-resistant Enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) and their synergism with antibiotics.[Pubmed:17408003]
Biocontrol Sci. 2007 Mar;12(1):7-14.
Two resveratrol trimers, Gnemonol B isolated from Gnetum gnemon and gnetin E obtained from the Gnetum species, were found to exhibit strong antibacterial activities against vancomycin-resistant Enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA). The MIC values of Gnemonol B against five strains of VRE and nine strains of MRSA were 12.5 and 6.25 microg/ml, respectively. The MIC values of gnetin E against five strains of VRE and nine strains of MRSA ranged from 12.5 to 25microg/ml. These compounds also showed synergistic effects when used in combination with commercially available antibiotics according to the evaluation method using FIC indices. These findings suggested that the application of the test compounds alone or in combination with antibiotics might be useful in controlling and treating VRE and MRSA infections